Form 4 for CALX CALIX, INC
Accepted 2023-10-30 00:00:00 ET · period of report 2023-10-27 · accession 0001406666-23-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-30 | 2023-10-27 | CALX | Collins John Matthew | Chief Commercial Ops Off | S - Sale+OE | $33.14 | -60.0K | 0 | -100% | -$1.99M |
| DM | 2023-10-30 | 2023-10-27 | CALX | Collins John Matthew | Chief Commercial Ops Off | M - OptEx | $8.32 | +60.0K | 30.0K | New | +$499.5K |
| DM | 2023-10-30 | 2023-10-27 | CALX | Collins John Matthew | Chief Commercial Ops Off | M - OptEx | $0.00 | -60.0K | 20.2K | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-27 | S | D | 60,000 | $33.14 | 0 | D | — | — | (F1) Shares sold between $32.39 and $34.12 per share at a weighted average price of $33.14. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. |
| 2 | Common | Common Stock | 2023-10-27 | M | A | 15,000 | $6.95 | 15,000 | D | — | — | |
| 3 | Common | Common Stock | 2023-10-27 | M | A | 30,000 | $9.16 | 60,000 | D | — | — | |
| 4 | Common | Common Stock | 2023-10-27 | M | A | 15,000 | $8.03 | 30,000 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 30,000 | $0.00 | 165,000 | D | $9.16 · — to 2030-01-31 | 30,000 Common Stock | (F4) 175,000 of the shares subject to the option grant were fully vested and exercisable on July 31, 2023. |
| 6 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 15,000 | $0.00 | 25,000 | D | $8.03 · — to 2029-02-14 | 15,000 Common Stock | (F3) 45,000 of the shares subject to the option grant were fully vested and exercisable on February 14, 2023. |
| 7 | Derivative | Stock Option (right to buy) | 2023-10-27 | M | D | 15,000 | $0.00 | 20,171 | D | $6.95 · — to 2027-08-01 | 15,000 Common Stock | (F2) 80,000 of the shares subject to the option grant were fully vested and exercisable on July 17, 2021. |